Johannesburg - South Africa faced the prospect yesterday of being taken to court by the country's leading AIDS group for denying HIV-positive pregnant women drugs that cut the risk of transmitting the disease to their newborn.
The Treatment Action Campaign is demanding a national programme to distribute a key antiretroviral drug called nevirapine to help reduce the 70,000 South African children born each year with HIV. The Pretoria Health Ministry reiterated its position that it was too early to begin nationwide provision of nevirapine.